Search Results for: us stem cell

Masayo Takahashi (高橋 政代): exciting vision work advancing including with photoreceptors

/ / 3 Comments
Masayo Takahashi, 高橋-政代.

Masayo Takahashi is a leading stem cell researcher doing translational and clinical research on vision. She’s doing pioneering work on using pluripotent stem cells as a basis for helping patients with vision loss such as due to macular degeneration. She won The Niche’s Stem Cell Person of the Year Award in 2014 and a number […]

Masayo Takahashi (高橋 政代): exciting vision work advancing including with photoreceptors Read More »

Monkey-pig chimeras pub discouraging for similar human research toward organ transplants

/ / Leave a Comment
pig-monkey-chimera-that-was-born-but-died

Michael Le Page over at The New Scientist reports on a new paper describing the birth of monkey-piglet chimeras. Unlike most such primate embryo chimeras formed in research in the past, these were allowed to be born. A litter of ten from the new monkey-pig research, two of which were chimeras, all rather quickly died

Monkey-pig chimeras pub discouraging for similar human research toward organ transplants Read More »

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

/ / 13 Comments
Roya-Panah-Kosolcharoen

Friday and Saturday showed a burst in FDA activity related to unproven stem cells and regenerative products including a warning letter to the unproven perinatal “stem cell” provider Liveyon. This was an unusual 48-hour period and a very good one for those who believe in science-based regenerative medicine but in my view a bad day

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms Read More »

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute

/ / 1 Comment
H-CYTE-Ann-Sells-Miller

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the

‘I’d need a drink’: WaPo deep dive on clinic firm Lung Health Institute Read More »

Unnatural Selection review: captivating mind-bender but needed more science

/ / 2 Comments
Unnatural-Selection-with-patient-Jackson-Kennedy

Today’s post is a review of Unnatural Selection, the new Netflix science docuseries focused on CRISPR and other disruptive genetic and reproductive technologies. The show is an interesting mix of personalities and stories from patients, scientists, biohackers, and more. One patient thread is the story of a wonderful little boy named Jackson Kennedy. He wants

Unnatural Selection review: captivating mind-bender but needed more science Read More »

ViaCyte Q&A: CRISPR Tx quick progress, ongoing diabetes trial, & more

/ / 9 Comments
ViaCyte-CyT49-PSC

ViaCyte is one of the most exciting stem cell and regenerative medicine biotech companies so I like to try to check in with them regularly. Today’s post is my new interview with ViaCyte leader Paul Laikind on recent developments. We had a great chat about the science and how things are looking upbeat for the

ViaCyte Q&A: CRISPR Tx quick progress, ongoing diabetes trial, & more Read More »

FDA Regenerative Medicine Advanced Therapy RMAT designations jump to 36

/ / 2 Comments
Peter-Marks-Regenerative-Medicine-Advanced-Therapy-Designation-RMAT-

This post includes my updated list of firms/products that have received FDA regenerative medicine advanced therapy designation or RMAT, which are in the public domain. The numbers really jumped in the last month. I’m assuming for the purposes of this resource page that all self-reports are accurate. Note that the links embedded into the firm

FDA Regenerative Medicine Advanced Therapy RMAT designations jump to 36 Read More »

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope

/ / 6 Comments
NSRichard08-headshot

A new right-to-try company called Beacon of Hope is stirring some intense discussion. State and federal right-to-try laws could potentially change the fabric of how many investigational studies are conducted. That may happen through firms like Beacon of Hope. However, we don’t know much about the firm. I’m hoping to help change that. Today’s post

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope Read More »

Northwestern abruptly ending Burt HSCT autoimmune trials

/ / 56 Comments
Selma-Blair-HSCT

“HSCT Chicago Clinic Closing!” is the startling header in all caps on a patient-run Facebook page about a stem cell therapy clinical trial program at Northwestern University. What’s going on? Unfortunately, the promising field of hematopoietic stem cell transplantation (HSCT) for multiple sclerosis (MS) and other autoimmune diseases seems to have suffered an unexpected setback

Northwestern abruptly ending Burt HSCT autoimmune trials Read More »

Dragon book

/
Knoepfler-How-to-Build-A-Dragon-book

My daughter Julie and I have written a book together entitled,  “How to Build a Dragon or Die Trying, A satirical look at cutting edge science.” The book will be out sometime in June most likely. This is a very different kind of book than my first two, Stem Cells: An Insider’s Guide and GMO

Dragon book Read More »